Found 17 matching trials
IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian Cancer PHASE2 This is a multicenter, randomized, double-blind, phase II clinical study to...
Show More Location
Cancer Hospital Chinese Academy of Medical Science and Peking Union Medical College
Learn More & Join Trial
IN10018 Combination Therapy in Treatment-naïve ES-SCLC PHASE1 This is a multicenter, open-label, Randomized, phase Ib/II clinical study t...
Show More Location
Shandong Province Cancer Hospital
Learn More & Join Trial
IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial PHASE2 Gastric-type adenocarcinoma of the cervix is the most commonly diagnosed HP...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation PHASE3 This is a multicenter, randomized, open-label, phase III clinical study, to...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors PHASE1 This is a multicenter, open-label, Phase Ib/II clinical study. The study in...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
IN10018 Monotherapy or in Combination With Docetaxel in Gastric or GEJ Adenocarcinoma PHASE1 This is a phase I, multi-center clinical trial to evaluate the safety, tole...
Show More Location
Anyang Tumor Hospital
Learn More & Join Trial
Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors PHASE1 This is a phase 1/2, open label study of D-1553 in combination with IN10018...
Show More Status
Active Not Recruiting
Location
Zhejiang Cancer Hospital, Cancer Hospital of the University of Chinese Academy of Sciences,
Learn More & Join Trial
IN10018 Combination Therapy in Previously-treated Solid Tumors PHASE1 This is a phase Ib/II, randomized, open-label, multicenter clinical trial t...
Show More Location
Multiple Locations
Learn More & Join Trial
IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC PHASE1 This is a multicenter, open-label, phase Ib/II clinical study to evaluate t...
Show More Location
Shanghai Pulmonary Hospital
Learn More & Join Trial
A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation PHASE1 This is a phase 1b, dose escalation and expansion study to evaluate the saf...
Show More Location
Guangdong Provincial People's Hospital
Learn More & Join Trial